Biotechnology
/
Eastern Norway

Biogauge Nordic Bioimpedance Research AS

Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
  • Finance
    Total revenues: 0
    Operating profit : -32
    Operating profit before tax: -32
    Total assets: 154
    Total equity: 152
    Currency: NOK (all numbers in thousands)
  • Management
    Board Chairman:
    Stein Harald Øvrebø

    Board Members:
    Thomas A Bydal Jakobsen
    Ørjan Grøttem Martinsen

    General Manager:
    Ørjan Grøttem Martinsen

    Subsidiary companies:
    Largest shareholders:
    N/A
    Biotechnology, Information Technology,